Attention providers
What is changing?
Effective for dates of service on and after July 1, 2024, based upon review of evidence provided by the Health Technology Clinical Committee (HTCC), the Health Care Authority (HCA) does not consider the following to be medically necessary for the treatment of knee and hip osteoarthritis:
- Hyaluronic acid (HA)
- Platelet-rich plasma (PRP)
This change will be reflected in the Physician-Related Services/Health Care Professional Services Billing Guide to be published for July 1, 2024.
|